Health, Fitness & Food

In this article DXCM Follow your favorite stocksCREATE FREE ACCOUNT Kevin Sayer, CEO, Dexcom Scott Mlyn | CNBC Shares of Dexcom fell 9% in extended trading on Thursday after the company released third-quarter results that beat analysts’ expectations but showed a decline in U.S. revenue year over year. Here’s how the company did: Earnings per
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer’s disease, suggesting its potential to delay or prevent the memory-robbing condition, according to a study released Thursday.  Semaglutide, the active ingredient in
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its popular weight loss injection
0 Comments
Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter. Danaher’s revenue for the three months ended Sept. 27 advanced 3% year over year on a reported basis, to $5.8 billion, outpacing the LSEG consensus estimate of $5.59 billion. On an organic basis, sales were
0 Comments
In this article NVDA GOOGL MSFT Follow your favorite stocksCREATE FREE ACCOUNT Visitors check out Nvidia’s AI technology at the 2024 Apsara Conference in Hangzhou, China, on September 19, 2024. Costfoto | Nurphoto | Getty Images Nvidia, Google, Microsoft and dozens of other tech companies are descending on Las Vegas next week to showcase artificial
0 Comments
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images Cancer drains individuals of their physical, emotional, and financial health. Given the impact on both patients and the people in their lives — including their employer — it’s time that CEOs take
0 Comments
In this article MRK Follow your favorite stocksCREATE FREE ACCOUNT The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew Kelly | Reuters Merck on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to
0 Comments
In this article WBA Follow your favorite stocksCREATE FREE ACCOUNT A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Tuesday reported fiscal fourth-quarter sales and adjusted profit that beat Wall Street’s expectations, as the company slashes
0 Comments
Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and upped its earnings guidance for the third straight quarter. Shares rose more than 1%, shaking off an initially subdued reaction. Revenue in the three months ended Sept. 30 rose 4.9% to $10.64 billion, topping estimates of $10.55 billion, according to data provider LSEG.
0 Comments
In this article NVAX Follow your favorite stocksCREATE FREE ACCOUNT A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Wednesday said the Food and Drug Administration
0 Comments
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk.  Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon and happy
0 Comments
About 165 million Americans get their health insurance through work, and yet most don’t spend much time considering what their employer is offering in the way of benefits and what it will cost. In fact, employees only spent about 45 minutes a year, on average, deciding which benefit options suit them best, a report from Aon found. Open
0 Comments